Pennsylvania-based Neuronetics raises $34.3 million that will be put to work, in part, on a trial testing its magnetic stimulation anti-depression device in adolescents.
Neuronetics said it raised $34.3 million in an equity offering slated to help broaden the use of its anti-depression device that relies on magnetic stimulation of the brain.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1bSISWE
Cap comentari:
Publica un comentari a l'entrada